Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
EPS 8.03 · 매출 173.5억. 세부 수치와 가이던스는 원문에서 확인하세요.
EPS 12.51 · 매출 186억. 세부 수치와 가이던스는 원문에서 확인하세요.
신규 편입 · 포트폴리오 비중 0.11%
신규 편입 · 포트폴리오 비중 0.08%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
EPS 컨센서스 4.63 · 매출 컨센서스 172.9억. 발표 후 실제치와 비교하세요.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| FY2026 Q3 | 2026. 09. 30. | Time TBD | — | $8.03 | — | — | $17.35B | Reported |
| FY2026 Q2 | 2026. 06. 30. | Time TBD | — | $12.51 | — | — | $18.6B | Reported |
| — | 2026. 04. 29. | After market close (AMC) | $4.63 | — | — | $17.29B | — | Scheduled |
| FY2026 Q1 | 2026. 03. 31. | Time TBD | — | $9.25 | — | — | $16.94B | Reported |
Consensus PT $277.14 · 22 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 08. | Keefe, Bruyette & Woods | — | Maintain | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2026. 05. 06. | Wells Fargo | — | Maintain | Equal-Weight → Equal-Weight | — | Wells Fargo: Equal-Weight |
| 2026. 05. 02. | Citigroup | — | Maintain | Neutral → Neutral | — | Citigroup: Neutral |
| 2026. 05. 02. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 04. 09. | Wells Fargo | — | Maintain | Equal-Weight → Equal-Weight | — | Wells Fargo: Equal-Weight |
| 2026. 04. 08. | Barclays | — | Maintain | Underweight → Underweight | — | Barclays: Underweight |
